Vertex Pharmaceuticals Inc / Ma
Nasdaq · Healthcare · Pharmaceutical Preparations · Boston, MA
VRTX chart
What traders are saying about $VRTX
Latest postsVertex Pharmaceuticals Inc / Ma news
- Amgen vs. Vertex Pharmaceuticals: Massive Pharmaceutical Scale vs. Steady Drug Revenue
fool.com ·
- Vertex Gears Up to Report Q3 Earnings: Is a Beat in the Cards?
Yahoo Finance ·
- BofA Names this Drugmaker a Top Pick on Promising Kidney Drug Data
Yahoo Finance ·
- Vertex Pharmaceuticals (VRTX) Stock Sinks As Market Gains: Here's Why
Yahoo Finance ·
- BHC Q3 Earnings Preview: Here's What You Should Know
Yahoo Finance ·
- The $500 Million Non-CF Factor Vertex Investors Can’t Ignore on Nov. 2
247wallst.com ·
- Vertex Pharmaceuticals (VRTX) Earnings Expected to Grow: Should You Buy?
Yahoo Finance ·
- Vertex Pharmaceuticals (VRTX) Posts Positive Phase 3 Results For Povetacicept
Yahoo Finance ·
- What Vertex Pharmaceuticals Holders Bought Into
Yahoo Finance ·
- Forget Casgevy: CRISPR Therapeutics' Heart-Disease Data Could Matter More
fool.com ·
- Vertex Pharmaceuticals Gets 96% of Product Sales From Treatments for 1 Disease. Here's Why That's About to Change.
fool.com ·
- Vertex Highlights Kidney Pipeline as Povetacicept Cuts Proteinuria 52% in Phase III
marketbeat.com ·
Vertex Pharmaceuticals Inc / Ma key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | $12.00B | $11.02B | $9.87B | $8.93B |
| Net income | $3.95B | -$535.6M | $3.62B | $3.32B |
| Diluted EPS | $15.32 | $-2.08 | $13.89 | $12.82 |
| Total assets (year end) | $25.64B | $22.53B | $22.73B | $18.15B |
| Cash and equivalents (year end) | $5.08B | $4.57B | $10.37B | $10.50B |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Vertex Pharmaceuticals Inc / Ma
- Ticker
- VRTX (Nasdaq)
- Industry
- Pharmaceutical Preparations
- Headquarters
- Boston, MA
- Incorporated in
- MA
- Fiscal year end
- December 31
- SEC CIK
- 875320
Frequently asked questions
What exchange is Vertex Pharmaceuticals Inc / Ma listed on?
Vertex Pharmaceuticals Inc / Ma trades on the Nasdaq under the ticker symbol VRTX.
What industry is Vertex Pharmaceuticals Inc / Ma in?
Vertex Pharmaceuticals Inc / Ma is classified by the SEC under "Pharmaceutical Preparations", part of the Healthcare sector on StockTweeting.
Where is Vertex Pharmaceuticals Inc / Ma headquartered?
Vertex Pharmaceuticals Inc / Ma's business address on file with the SEC is in Boston, MA.
When does Vertex Pharmaceuticals Inc / Ma's fiscal year end?
Vertex Pharmaceuticals Inc / Ma's fiscal year ends on December 31.
How much revenue did Vertex Pharmaceuticals Inc / Ma report?
Vertex Pharmaceuticals Inc / Ma reported $12.00B in revenue for calendar year 2025, according to its SEC filings.